| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9310770 | Kidney International | 2005 | 8 Pages | 
Abstract
												One- and 2-year graft survival is comparable to other high-risk populations receiving kidney transplantation. One- and 2-year patient survival is higher than HIV patients maintained on dialysis. Immunosuppression does not adversely affect HIV recipients maintained on HAART in the short term.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Nephrology
												
											Authors
												Mysore S. Anil Kumar, Debra R. Sierka, Anna M. Damask, Billie Fyfe, Robert F. Mcalack, Michael Heifets, Michael J. Moritz, Daniel Alvarez, Aparna Kumar, 
											